COVID-19 resources / Clinical Research Insights and News

The Cohortias Blog

Stay informed

COVID-19 resources

Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.

Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.

Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.

clinical research

Cohortias – Clinical research landscape in Latin America.

Reduced costs, easier and faster subject recruitment and faster regulatory approvals have boosted foreign investment in clinical research in Latin America.

pancreatic cancer

Clinical Trial – Phase I/IIa pancreatic cancer trial.

PBP1510 received Orphan Drug Designation from the FDA, the European Medicines Agency and Korean MFDS, in 2020.

Multiple system atrophy therapy

Clinical Trial – Multiple system atrophy therapy.

The randomized, double-blind, placebo-controlled trial will analyze ATH434 in early-stage MSA patients.

atopic dermatitis

Clinical Trial – Phase IIa atopic dermatitis therapy trial.

The trial will analyze the safety and efficacy of the treatment with FMX114 in AD patients versus vehicle control.

COVID-19 Research - Free Consultation

The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.

covid clinical trials

The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.